… cardiac effects of the tricyclic antidepressants (TCAs) have been well characterized. In contrast,
the cardiac effects of the selective serotonin reuptake inhibitors (… reports of cardiac effects …

… function as safe and efficacious agents against depression, platelet … of coronary artery disease
and congestive heart failure. … serotonin reuptake inhibitors in patients with depression and …

… Among the novel risk factors in coronary artery disease (CAD) patients, the importance of
depression has been … After the safety of one of the SSRIs (fluoxetine) in depressed patients with …

… of ischemic heart disease (IHD) and poor prognosis of patients … depression treatment, selective
serotonin reuptake inhibitors (… as well as the cardiac safety of sertraline hydrochloride for …

… year 2020, depression and ischemic heart disease will be … used to measure the medications'
safety. There were no differences … , appeared safe for use in depressed patients with recent …

… with comorbid ischemic heart disease (IHD), the cardiovascular … the safety of various
antidepressant classes, specifically the tricyclics and selective serotonin reuptake inhibitors (SSRIs) …

… serotonin reuptake inhibitors (SSRIs) are commonly used in patients with coronary artery
disease and depression… -SSRI antidepressant use after coronary artery bypass grafting (CABG) …

… , certain selective serotonin reuptake inhibitors (… patients with ischemic heart disease. SSRIs
and potentially SNRIs are relatively safe and effective options for patients with heart failure. …

… (TCAs), selective serotonin reuptake inhibitors (SSRIs), and … depression in the patient with
ischemic heart disease (IHD), … proven to be safe and effective for depression in patients with …

… Selective serotonin reuptake inhibitors (SSRIs) are among the most commonly used … patients
with ischemic heart disease (IHD). Data on cardiovascular (CV) safety of SSRIs in patients …